CanSino Biologics Inc. (FRA:CJH)
Germany · Delayed Price · Currency is EUR 3.916
-0.116 (-2.88%)
Last updated: Jan 28, 2026, 3:25 PM CET
CanSino Biologics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -142.03 | -378.88 | -1,483 | -909.43 | 1,914 | -396.64 |
Depreciation & Amortization | 195.25 | 195.25 | 263.24 | 189.22 | 73.36 | 24.59 |
Other Amortization | 21.58 | 21.58 | 6.3 | 7.14 | 15.18 | 7.22 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | -0.02 | - | - | - |
Asset Writedown & Restructuring Costs | 1.32 | 1.32 | 362.7 | 0.25 | 0.25 | 0.53 |
Loss (Gain) From Sale of Investments | 43.1 | 43.1 | -42.63 | -76.63 | -71.86 | -38.68 |
Stock-Based Compensation | 3.2 | 3.2 | 9.54 | 10.08 | 9.8 | - |
Provision & Write-off of Bad Debts | 15.15 | 15.15 | 15.05 | 8.78 | 1.82 | - |
Other Operating Activities | 144.32 | 60.26 | 139.98 | 624.87 | -6.58 | 43.5 |
Change in Accounts Receivable | -78.56 | -78.56 | 265.97 | -495.8 | -419.94 | -107.76 |
Change in Inventory | -0.68 | -0.68 | -216.54 | -604.02 | -706.39 | -154.57 |
Change in Accounts Payable | -106.27 | -106.27 | -223.19 | -429.93 | 1,212 | 155.58 |
Change in Unearned Revenue | 54.38 | 54.38 | -5.64 | 20.88 | 27.52 | - |
Change in Other Net Operating Assets | 0.38 | 0.38 | 11.2 | - | - | 2.11 |
Operating Cash Flow | 153.62 | -167.29 | -908.23 | -1,852 | 2,050 | -349.93 |
Capital Expenditures | -310.23 | -457.64 | -610.47 | -1,075 | -1,203 | -288.29 |
Sale of Property, Plant & Equipment | 0.29 | 0.04 | 0.31 | - | - | - |
Cash Acquisitions | -1.31 | -1.31 | -0.34 | - | - | - |
Investment in Securities | 820.55 | 377.48 | 99.25 | -697.83 | -1,403 | -60.06 |
Other Investing Activities | -182.26 | 83.89 | 61.59 | 545.21 | 45.77 | 28.66 |
Investing Cash Flow | 327.04 | 2.46 | -449.65 | -1,228 | -2,560 | -319.69 |
Short-Term Debt Issued | - | - | 50.46 | - | - | - |
Long-Term Debt Issued | - | 1,043 | 1,635 | 2,634 | 1,150 | - |
Total Debt Issued | 1,100 | 1,043 | 1,685 | 2,634 | 1,150 | - |
Short-Term Debt Repaid | - | - | -20.58 | - | - | - |
Long-Term Debt Repaid | - | -1,314 | -1,615 | -1,388 | -181 | -22.49 |
Total Debt Repaid | -1,775 | -1,314 | -1,636 | -1,388 | -181 | -22.49 |
Net Debt Issued (Repaid) | -674.88 | -270.47 | 49.32 | 1,246 | 969.13 | -22.49 |
Issuance of Common Stock | - | - | 16.98 | - | - | 4,984 |
Repurchase of Common Stock | - | - | - | -150.17 | - | - |
Common Dividends Paid | -51.14 | -63.78 | -73.75 | -241.28 | -14.1 | -6.69 |
Other Financing Activities | 2.93 | 0.07 | -0.14 | -0.37 | 598.59 | -13.55 |
Financing Cash Flow | -723.1 | -334.18 | -7.58 | 854.23 | 1,554 | 4,941 |
Foreign Exchange Rate Adjustments | 3.46 | 8.72 | 20.29 | 160.76 | -33.78 | -27.36 |
Net Cash Flow | -238.97 | -490.29 | -1,345 | -2,064 | 1,009 | 4,244 |
Free Cash Flow | -156.61 | -624.93 | -1,519 | -2,927 | 846.86 | -638.23 |
Free Cash Flow Margin | -16.11% | -73.84% | -425.31% | -282.87% | 19.70% | -2564.19% |
Free Cash Flow Per Share | -0.65 | -2.52 | -6.16 | -11.84 | 3.42 | -2.77 |
Cash Income Tax Paid | 70.06 | 25.19 | -24.05 | -77.91 | -162.45 | -5.99 |
Levered Free Cash Flow | -245.67 | -860.93 | -908.45 | -2,557 | 185.99 | -564.56 |
Unlevered Free Cash Flow | -215.06 | -823.44 | -868.36 | -2,531 | 198.76 | -564.56 |
Change in Working Capital | -128.3 | -128.3 | -179.65 | -1,706 | 113.64 | 9.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.